glutamine has been researched along with Mesenteric Vascular Occlusion in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bick, RJ; Desoignie, R; Kozar, RA; Moore, FA; Poindexter, BJ; Sato, N; Schultz, SG; Verner-Cole, E | 1 |
Kozar, RA; Moore, FA; Moore-Olufemi, S; Sato, N; Schultz, SG; Smith, MA; Zou, L | 1 |
2 other study(ies) available for glutamine and Mesenteric Vascular Occlusion
Article | Year |
---|---|
The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion.
Topics: Actins; Adjuvants, Immunologic; Analysis of Variance; Animals; Arginine; Cell Membrane Permeability; Cytoskeleton; Enteral Nutrition; Glutamine; Intestinal Mucosa; Male; Mesenteric Vascular Occlusion; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2004 |
Immune-enhancing enteral nutrients differentially modulate the early proinflammatory transcription factors mediating gut ischemia/reperfusion.
Topics: Analysis of Variance; Animals; Arginine; Disease Models, Animal; Drug Evaluation, Preclinical; Electrophoretic Mobility Shift Assay; Enteral Nutrition; Glutamine; Immunity, Mucosal; Immunologic Factors; Inflammation; Jejunum; Male; Mesenteric Artery, Superior; Mesenteric Vascular Occlusion; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Patient Selection; Peroxisome Proliferator-Activated Receptors; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Risk Factors; Time Factors; Transcription Factor AP-1 | 2005 |